Sancilio and Company, Inc., (SCI) is a vertically integrated biopharmaceutical company founded by Fred Sancilio, PhD, in 2007 and headquartered in Riviera Beach, Florida. We are uniquely positioned in the marketplace, leveraging our long-term relationships for quality products with demand in both the retail and institutional segments.
Sancilio and Company is an emerging generic pharmaceutical company that specializes in the development, manufacture, and sale of cardiovascular, dental, and women’s health products. Product offerings include Ocean Blue®
Professional Omega-3 2100™ , which contains 2100 mg of omega-3 per serving, chewable and liquid prescription sodium fluoride supplements for the prevention of cavities in children, and prescription chewable prenatal vitamins for women who are pregnant or may become pregnant. We have a robust product pipeline utilizing a state-of-the-art manufacturing facility, with several products in various stages of development.
Our Florida-based research laboratories are staffed with highly qualified and experienced scientists, and our fully operational cGMP production facilities enable us to manufacture products that are then sold through our domestic and international distribution channels. The SCI team currently consists of approximately 70 employees, including 5 PhDs.
All Sancilio products are manufactured in the United States.
Additional information about SCI can be found at www.sancilio.com